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ABSTRACT
Introduction: In the UK, several hundred patients notified with tuberculosis (TB) die every year. The aim
of this article is to describe trends in deaths among notified TB patients, explore risk factors associated
with death and compare all-cause mortality in TB patients with age-specific mortality rates in the general
UK population.
Methods: We used 2001–2014 data from UK national TB surveillance to explore trends and risk factors
for death, and population mortality data to compare age-specific death rates among notified TB patients
with annual death rates in the UK general population.
Results: The proportion of TB patients in the UK who died each year declined steadily from 7.1% in 2002
to 5.5% in 2014. One in five patients (21.3%) was diagnosed with TB post-mortem. Where information
was available, almost half of the deaths occurred within 2 months of starting treatment. Risk factors for
death included demographic, disease-specific and social risk factors. Age had by far the largest effect, with
patients aged ⩾80 years having a 70 times increased risk of death compared with those aged <15 years. In
contrast, excess mortality determined by incidence ratios comparing all-cause mortality among TB patients
with that of the general population was highest among children and the working-age population
(15–64 years old).
Conclusions: Efforts to control TB and improve diagnosis and treatment outcomes in the UK need to be
sustained. Control efforts need to focus on socially deprived and vulnerable groups. There is a need for
further in-depth analysis of deaths of TB patients in the UK to identify potentially preventable factors.
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Introduction
The 2018 Global Tuberculosis (TB) Report published by the World Health Organization (WHO)
estimated 10 million TB incident patients and 1.6 million TB-related deaths in 2017 [1]. While the
majority of TB-related deaths occur in low-income countries, high all-cause mortality is also seen among
TB patients in Western Europe. TB mortality rates have declined globally with an annualised rate of
change of −4.1% from 2005 to 2015. Within the European Union, mortality rates declined even faster with
an estimated annual percentage change of −8.1% for females and −7% for males between 2000 and 2010
[2]. However, to achieve the milestone for reduction in TB deaths set in the WHO’s End TB Strategy, the
global case fatality rate (CFR) needs to fall to 10% by 2020 and 6% by 2025 [1]. In high-income countries,
socioeconomic status, noninfective comorbidities, sputum smear positivity and alcohol or substance abuse
are all associated with higher mortality among TB patients [3–6].
The UK, like many other European countries, has seen a remarkable decline in TB notifications and
mortality over the last 100 years [7]. However, in recent years the decline in mortality has been slower
compared with the average TB mortality decline in the European Region between 2000 and 2010 (−4.6%
in the UK versus −7% in the European Union) [2]. A possible explanation may be the concentration of
the TB epidemic in major cities, among foreign-born residents, recent immigrants and certain groups of
socially marginalised citizens [8].
In this article, using data from national TB surveillance, we describe trends in deaths, explore risk factors
associated with death among notified TB patients in the UK and compare all-cause mortality in TB
patients with overall age-specific mortality rates in the UK, in order to inform TB control strategies with
an aim of reducing mortality in TB patients.
Methods
TB patients notified to national TB surveillance in the UK between January 1, 2001 and December 31,
2014 were included in this analysis. 2014 was the most recent year of notification to allow the TB patients
included up to 24 months of follow-up.
In the UK, there is a statutory requirement to notify all TB patients, including patients that died prior to
starting treatment or identified post-mortem [9]. TB patients in England, Wales and Northern Ireland are
notified to the Public Health England Enhanced Tuberculosis Surveillance System; these data are compiled
with patients notified to the Enhanced Surveillance of Mycobacterial Infections system in Scotland to
create a complete UK dataset. Case data are matched to laboratory data on Mycobacterium tuberculosis
complex isolates through a probabilistic record linkage (Enhanced Matching System) [10]. Demographic
data (age, sex, UK/non-UK born, ethnic group) and clinical variables (site of disease, notification date,
smear and culture results) were included. Data on social risk factors (i.e. current or history of
homelessness, imprisonment or drug misuse and current alcohol misuse) were included from 2010, when
these variables were being recorded for >75% of patients.
Follow-up information is collected on outcomes for all TB patients at 12 months from the treatment start
date or the notification date if the treatment start date is not reported. For patients still on treatment at
12 months (7.5% of patients during the study period), follow-up is extended to 24 and 36 months as
appropriate. The outcomes are recorded as “treatment completed”, “died”, “lost to follow-up”, “still on
treatment”, “stopped” or “not evaluated”. Reporting of TB outcomes in the UK is proactively followed up
by regional and national TB surveillance teams. For the outcome “died”, additional information is
collected on whether TB caused or contributed to death, or whether TB was incidental to death.
We obtained mid-year population estimates and total annual deaths stratified by 5-year age groups for
England and Wales from the Office for National Statistics, for Northern Ireland from the Northern Ireland
Statistics and Research Agency, and for Scotland from the National Records of Scotland. We used these
data to compare all-cause mortality rates among notified TB patients during their follow-up period with
annual mortality rates in the UK general population.
Analyses
We used descriptive statistics to describe trends in the number and proportion of deaths among notified
TB patients. The proportion of deaths among notified TB patients is not the same as the CFR, which is
defined as the proportion of TB patients dying due to TB. We analysed all deaths in TB patients, rather
than only deaths reported as caused by TB, as data were missing on whether TB caused, contributed to or
was incidental to death for 43% of patients during the study period. In addition, there is a poor correlation
between cause of death information in the TB surveillance system and in the vital registration system [11],
suggesting that cause of death is not accurately reported.
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We performed univariable analyses to identify the characteristics of TB patients who died. We performed
univariable logistic regression to identify risk factors associated with death. We conducted multivariable
logistic regression using all factors from the univariable analyses to calculate adjusted odds ratios (aORs).
We repeated the analysis on a subset of data for the period 2010–2014 to investigate the association
between social risk factors and death among TB patients. We conducted this analysis to ascertain any
difference between patients that have at least one social risk factor recorded and those that do not have
any social risk factor recorded (supplementary table S1).
Finally, we calculated incidence risk ratios (IRRs) to compare the risk of death among TB patients with the
annual risk of death in the general UK population, stratified by age groups for the same period of analysis
(2001–2014). We performed the analyses using Stata version 13.1 (StataCorp, College Station, TX, USA).
Ethics statement
Public Health England has authority to hold and analyse national surveillance data for public health and
research purposes under the Health and Social Care Act 2012.
Results
Between January 1, 2001 and December 31, 2014, a total of 111991 TB patients were notified in the UK.
Outcomes were recorded for 92.6% (103727) of patients. 78.9% (88352) completed treatment, 4.7% (5251)
were lost to follow-up, 2.1% (2366) were still on treatment and 1.1% (1218) had their treatment stopped
by the last reported outcome. 5.8% (6540) of TB patients died during the follow-up period after
notification. TB caused or contributed to 34.7% (2269) of deaths, was incidental to 22.3% (1457) of deaths,
and the relationship between TB and death was unknown for 43.0% (2814) of deaths. Among those who
died, 21.4% (1398 out of 6540) were diagnosed post-mortem and no treatment for TB was started. Of the
remaining deaths, 55.2% (2840 out of 5142) had information on the time between starting treatment and
death. The median (interquartile range) time to death after starting treatment was 38 (12–97) days; 61.7%
(1752) died within 2 months, 19.0% (539) died between 2 and 4 months, 8.4% (237) died between 4 and
6 months, and 11.0% died after at least 6 months of treatment.
The proportion of TB patients who had died at last reported outcome decreased from 6.8% (462 deaths) in
2001 to its lowest in 2013 (4.9%; 387 deaths) before increasing slightly in 2014 to 5.5% (389 deaths) (test
for linear p<0.01) (figure 1). All-cause mortality rates among TB patients decreased from 0.78 per 100000
population in 2001 to 0.60 per 100000 population in 2014.
With the exception of children <5 years of age (among whom 1.2% died), the proportion of TB patients
who died increased with increasing age, from 0.3% in those aged 5–9 years to 19% in those aged
65–79 years and 38% among those aged ⩾80 years (table 1 and figure 2).
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In the univariable analysis, TB patients who were male, born in the UK or of White ethnicity had the
highest odds of death (table 1). In the fully adjusted model (table 1), older age was the factor most strongly
associated with death, with those aged 65–79 years 30 times (OR 30.09, 95% CI 20.84–43.44) more likely
to die and with those aged ⩾80 years 70 times (OR 70.80, 95% CI 48.84–102.63) more likely to die
compared with children aged 0–14 years. The other factors that remained significantly associated with
death were multidrug-resistant (MDR)-TB (OR 2.40, 95% CI 1.66–3.48), male sex (OR 1.40, 95% CI
1.33–1.48), UK born of White or Black African ethnicity (OR 1.35, 95% CI 1.19–1.54) and having had a
previous TB diagnosis (OR 1.16, 95% CI 1.05–1.28). Having only extrapulmonary disease was associated
with decreased odds of death (OR 0.46, 95% CI 0.42–0.51).
Association between social risk factors and death
Between 2010 and 2014, 40921 TB patients were notified, 81.7% (33433) of whom had information on
social risk factors. 10.1% (3207) were reported to have at least one social risk factor. Among the patients
that died, 17% (230 out of 1365) had at least one social risk factor. The proportion of patients who died
was higher among TB patients with any social risk factor (history of alcohol misuse/abuse, problem drug
use, homelessness and imprisonment) compared with those without any social risk factors (7.2% (230 out
of 3726) versus 3.8% (1135 out of 30226)).
TABLE 1 Descriptive, univariable and multivariate analysis of mortality among tuberculosis
(TB) patients in the UK, 2001–2014
TB
patients n
Deaths
n (%)
Univariable analysis
OR (95% CI)
Multivariate analysis
aOR (95% CI)
Overall 111991 6540 (5.8)
Sex
Male 62628 4161 (6.6) 1.40 (1.33–1.48) 1.37 (1.28–1.47)
Female 49146 2371 (4.8) 1.00 1.00
Age group years
0–14 5682 40 (0.7) 1.00 1.00
15–44 66863 903 (1.4) 1.93 (1.41–2.65) 1.87 (1.29–2.71)
45–64 22704 1516 (6.7) 10.09 (7.36–13.83) 9.11 (6.31–13.16)
65–79 12094 2324 (19.2) 33.55 (24.5–45.94) 30.09 (20.84–43.44)
⩾80 4630 1757 (38.0) 86.26 (62.85–118.39) 70.80 (48.84–102.63)
Place of birth
UK 30068 3062 (10.2) 3.21 (3.04–3.39) 1.35 (1.19–1.54)
Non-UK 73902 2524 (3.4) 1.00 1.00
Ethnic group
White 25650 3594 (14.1) 4.05 (3.76–4.36) 1.17 (1.01–1.35)
Black African 21764 522 (2.4) 0.61 (0.55–0.68) 1.23 (1.07–1.41)
Indian 24276 940 (3.9) 1.00 1.00
Pakistani 16827 657 (3.9) 1.01 (0.91–1.11) 0.90 (0.79–1.02)
Bangladeshi 3787 104 (2.8) 0.70 (0.57–0.86) 0.95 (0.74–1.22)
Other 15764 431 (2.7) 0.70 (0.62–0.78) 0.77 (0.67–0.89)
Site of disease
Pulmonary sputum
smear-positive
22526 1722 (7.6) 1.00 1.00
Pulmonary sputum
smear-negative or
unknown
39933 3262 (8.2) 1.07 (1.01–1.14) 0.91 (0.83–0.98)
Extrapulmonary 49136 1531 (3.1) 0.39 (0.36–0.42) 0.46 (0.42–0.51)
Previous TB diagnosis
Yes 7743 710 (9.2) 2.03 (1.87–2.21) 1.16 (1.05–1.28)
No 88258 4181 (4.7) 1.00 1.00
MDR-TB
Yes 806 47 (5.8) 0.96 (0.71–1.28) 2.40 (1.66–3.48)
No 65304 3975 (6.1) 1.00 1.00
Unknown (no culture
or DSTs)
45881 2518 (5.5) 0.90 (0.85–0.94) 0.96 (0.89–1.03)
aOR: adjusted OR; MDR: multidrug-resistant; DST: drug susceptibility test. Missing values: sex n=217,
age n=12661, place of birth n=8021, ethnic group n=3923, site of disease n=396, previous TB diagnosis
n=15990 and MDR-TB n=0.
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In the multivariable analysis adjusted for age, sex, place of birth, ethnicity, site of disease and drug
susceptibility, TB patients who died were 2.2 times more likely to have one or more social risk factors
(table 2). MDR-TB (OR 2.47, 95% CI 1.28–4.75), male sex (OR 1.29, 95% CI 1.13–1.48) and increasing
age remained associated with death, while White ethnicity and being born in the UK did not. Findings
from this analysis showed that there was no significant difference between TB patients with available
information on social risk factors and those with missing information (supplementary table S1).
Comparing mortality among TB patients with mortality in the general UK population
We found that all-cause mortality rates were significantly higher among notified TB patients than the UK
general population across all age groups (figure 3). Overall, TB patients had a 6 times greater risk of death
during their follow-up period compared with the annual risk of death in the general population (IRR 6.2,
95% CI 6.1–6.4). IRRs were highest in those aged 5–9 years (IRR 46.7, 95% CI 15.2–109.2) and
10–14 years (IRR 58.3, 95% CI 29.1–104.4), although confidence intervals were very large due to the very
small number of children and adolescents with TB who died. In the age group 15–54 years, IRRs were
consistently >20 and decreased in older age groups, down to 3.6 in those aged ⩾85 years.
Discussion
This study shows that the proportion of TB patients in the UK who died declined steadily from 7.1% in
2002 to 5.5% in 2014. Of these deaths, 21.3% were diagnosed with TB post-mortem, and almost half
(48.5%) of those who started treatment and for whom information was available died within 2 months of
starting treatment. Risk factors for death included demographic, disease-specific and social risk factors.
Age had by far the largest effect, with TB patients aged ⩾80 years having a 70 times increased risk of
death compared with those aged <15 years. In contrast, excess mortality determined by incidence ratios
comparing all-cause mortality among TB patients with that of the general population was highest among
children aged ⩾5 years followed by the working-age population (15–64 year olds).
Overall, 5.8% of TB patients in this cohort died, which compares favourably with other high-income
countries in Europe, Canada and Israel [12–16], but higher than reported from low-income settings [17].
This likely reflects differences in the age structure of TB patients; in low-income settings TB mainly affects
young individuals of working age, while in high-income settings a high proportion of TB patients are
elderly [12, 14, 18].
In this study, more than a fifth of TB patients who died were diagnosed with TB after they died. The
number of post-mortem TB diagnoses greatly depends on autopsy rates in the country. These vary
considerably across countries and have steadily declined over the past four decades [19–23]. The fact that
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the majority of TB patients who had information on treatment start date and date of death died within
2 months of starting treatment, and that a large number of TB diagnoses were made post-mortem,
suggests that earlier diagnosis may be key to reducing mortality. Studies from the UK and Spain have
shown a considerable diagnostic delay between symptom onset, TB diagnosis and treatment initiation [24, 25].
The elderly may be particularly at risk of being diagnosed late due to atypical clinical presentations and
chest radiography findings, which may be interpreted as changes related to older age [26–28].
Risk factors for death among TB patients in this study were older age, male sex, born in the UK,
pulmonary TB, smear-positive disease, previous TB and MDR-TB. Other studies from low TB incidence
settings have found similar associations [12, 14, 15, 29]. In addition, our study found that having any
social risk factor, such as current or history of homelessness, imprisonment or drug misuse and current
alcohol misuse, doubled the risk of dying even after controlling for the demographic and disease-specific
risk factors. Studies based on surveillance data rarely investigate the effect of social risk factors, as social
risk factors are not routinely collected in many surveillance systems. However, previous studies using
regional data have shown that current alcohol misuse and unemployment increase the risk of death among
TB patients [30–33]. A recent study using data from 11 European countries showed substantial educational
TABLE 2 Descriptive, univariable and multivariate analysis including social risk factors of the
number of deaths among tuberculosis (TB) patients in the UK, 2010–2014
TB
patients n
Deaths
n (%)
Univariable analysis
OR (95% CI)
Multivariate analysis
aOR (95% CI)
Overall 40921 2117 (5.2)
Sex
Male 23571 1384 (5.9) 1.42 (1.29–1.55) 1.29 (1.13–1.48)
Female 17279 729 (4.2) 1.00 1.00
Age group years
0–14 1793 10 (0.6) 1.00 1.00
15–44 24439 211 (0.9) 1.55 (0.82–2.93) 1.55 (0.62–3.84)
45–64 8876 522 (5.9) 11.14 (5.95–20.87) 10.37 (4.22–25.49)
65–79 4123 753 (18.3) 39.84 (21.29–74.54) 42.35 (17.26–103.93)
⩾80 1690 621 (36.8) 103.58 (55.20–194.35) 109.70 (44.5–270.38)
Place of birth
UK 28799 959 (8.9) 2.96 (2.40–3.25) 1.21 (0.96–1.53)
Non-UK 10732 923 (3.2) 1.00 1.00
Ethnic group
White 8778 1086 (12.4) 3.98 (3.51–4.50) 1.05 (0.81–1.37)
Black African 6640 128 (1.9) 0.55 (0.45–0.68) 0.86 (0.64–1.14)
Indian 10263 352 (3.4) 1.00 1.00
Pakistani 6599 259 (3.9) 1.15 (0.98–1.35) 0.91 (0.73–1.13)
Bangladeshi 1518 42 (2.8) 0.80 (0.58–1.11) 0.83 (0.52–1.33)
Other 6167 155 (2.5) 0.73 (0.60–0.88) 0.75 (0.58–0.96)
Site of disease
Pulmonary sputum
smear-positive
13592 1142 (7.8) 1.00 1.00
Pulmonary sputum
smear-negative or
unknown
6839 441 (6.5) 1.22 (1.09–1.37) 0.90 (0.77–1.07)
Extrapulmonary 19185 523 (2.7) 0.41 (0.36–0.46) 0.47 (0.38–0.57)
Previous TB diagnosis
Yes 2689 215 (8.0) 2.04 (1.76–2.37) 1.20 (0.98–1.47)
No 36040 1471 (4.1) 1.00 1.00
MDR-TB
Yes 366 15 (4.1) 0.73 (0.43–1.23) 2.47 (1.28–4.75)
No 24331 1346 (5.5) 1.00 1.00
Unknown (no culture
or DSTs)
16224 756 (4.7) 0.83 (0.76–0.91) 0.96 (0.84–1.11)
Social risk factors
⩾1 3207 230 (7.2) 1.98 (1.71–2.29) 2.23 (1.83–2.71)
0 30226 1135 (3.8) 1.00 1.00
aOR: adjusted OR; MDR: multidrug-resistant; DST: drug susceptibility test.
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inequality in TB mortality, with higher death rates among those with lower educational levels compared
with higher educational levels [34]. Taken together, these findings suggest that interventions aiming at
earlier TB diagnosis and prompt initiation of treatment for socially deprived vulnerable groups are needed
to decrease inequalities in TB mortality.
As would be expected, advancing age is the most prominent risk factor for all-cause mortality in TB
patients. However, the association between age and death among TB patients does not accurately depict
the true burden of excess mortality in TB patients. Comparison with the general population revealed a
significant excess all-cause mortality in TB patients across all age groups, but particularly in children aged
⩾5 years followed by those aged 15–64 years. These results are in line with other studies from Taiwan, the
Netherlands and Southern India [35–37].
This study has several important strengths. The study used data from a large national cohort with
near-complete outcome reporting [11] and a high proportion of records with known date of death.
Furthermore, the comparison with the general population allowed calculation of IRRs across age groups.
To the best our knowledge, it is the first study of national surveillance data investigating the impact of
social risk factors on death.
There are a few limitations to our study. Data on disease severity and comorbidities are not routinely
captured by the surveillance system. Data on the relationship between TB and death were poorly
completed in the surveillance system, so it was not possible to calculate the CFR. All-cause mortality
rather than mortality due to TB was presented as the information on cause of death was often not
recorded or may not have been accurately recorded as identified by comparing with information recorded
in the UK’s vital registration system [11]. An audit is planned to clarify why these differences occur and to
inform development of clear guidance to improve reporting. In addition, TB/HIV co-infection data were
not available and thus the impact of HIV could not be analysed. However, only 5% of TB patients were
HIV-positive in the UK during the study period [38]. A considerable proportion of social risk factor data
was missing during the study period; however, comparison of individuals with and without social risk
factor information did not show any significant difference. Finally, in the comparison of mortality rates in
TB patients with the general population it was not possible to control for any confounders apart from age.
In addition, the follow-up period for the majority of TB patients was <12 months, so the comparison of
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the all-cause mortality in TB patients with annual mortality rates in the general population would have led
to conservative estimates of the excess mortality in TB patients.
Conclusions
Despite an overall decline in death among TB patients in the UK during the study period, patients with
TB are still 6 times more likely to die during follow-up than the annual death rate in the general
population, and this excess mortality is particularly marked for children and working-age adults. While
not all deaths in patients with TB are directly related to their TB disease, this high excess mortality clearly
demonstrates the poor overall health and high vulnerability of the population with TB in the UK. The fact
that TB patients generally die early in their course of TB treatment and a proportion are only diagnosed
with TB post-mortem suggests that earlier diagnosis may be key to reducing TB-related mortality. The fact
that TB patients with social risk factors are twice as likely to die as those without social risk factors
suggests that efforts to reduce mortality need to specifically address the needs of socially deprived groups.
This is particularly important given recent changes in TB epidemiology in the UK, with an increase in the
proportion of patients with social risk factors as overall case numbers fall [39]. There is a need for further
in-depth analysis of individual TB deaths to identify specific avoidable factors that can be addressed across
the full pathway from health-seeking behaviour and access to services, through to diagnosis, treatment
initiation and treatment completion.
Conflict of interest: None declared.
References
1 World Health Organization. Global Tuberculosis Report 2018. 2018. www.who.int/tb/publications/global_report/en
Date last accessed: October 25, 2019.
2 Al-Rahamneh MJ, Al-Rahamneh A, Guillén-Grima F, et al. Mortality trends for tuberculosis in European Union
countries, 2000–2010. Enferm Infecc Microbiol Clin 2018; 36: 342–351.
3 Marx FM, Fiebig L, Hauer B, et al. Higher rate of tuberculosis in second generation migrants compared to native
residents in a metropolitan setting in Western Europe. PLoS One 2015; 10: e0119693.
4 Kodmon C, Zucs P, van der Werf MJ. Migration-related tuberculosis: epidemiology and characteristics of
tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Euro
Surveill 2016; 21: 30164.
5 Walker TM, Lalor MK, Broda A, et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK,
2007–12, with whole pathogen genome sequences: an observational study. Lancet Respir Med 2014; 2: 285–292.
6 Story A, Murad S, Roberts W, et al. Tuberculosis in London: the importance of homelessness, problem drug use
and prison. Thorax 2007; 62: 667–671.
7 Public Health England. Tuberculosis mortality and mortality rate, England and Wales, 1913–2013. 2013. www.gov.
uk/government/publications/tuberculosis-tb-annual-notifications-1913-onwards Date last updated: July 25, 2019.
Date last accessed: October 25, 2019.
8 Abubakar I, Lipman M, Anderson C, et al. Tuberculosis in the UK – time to regain control. BMJ 2011; 343:
d4281.
9 Public Health England. Guidance on notifying tuberculosis (TB) cases. 2014. www.gov.uk/government/
publications/tuberculosis-notifying-cases Date last accessed: October 25, 2019.
10 Aldridge RW, Shaji K, Hayward AC, et al. Accuracy of probabilistic linkage using the Enhanced Matching System
for public health and epidemiological studies. PLoS One 2015; 10: e0136179.
11 Lalor MK, Mohiyuddin T, Uddin T, et al. The challenge of estimating tuberculosis mortality accurately in England
and Wales. Int J Tuberc Lung Dis 2018; 22: 572–578.
12 Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur
Respir J 2008; 31: 1256–1260.
13 Vachon J, Gallant V, Siu W. Tuberculosis in Canada, 2016. Can Commun Dis Rep 2018; 44: 75–81.
14 Karo B, Hauer B, Hollo V, et al. Tuberculosis treatment outcome in the European Union and European Economic
Area: an analysis of surveillance data from 2002–2011. Euro Surveill 2015; 20 30087.
15 Shuldiner J, Leventhal A, Chemtob D, et al. Mortality of tuberculosis patients during treatment in Israel,
2000–2010. Int J Tuberc Lung Dis 2014; 18: 818–823.
16 European Centre for Disease Prevention and Control, World Health Organization Regional Office for Europe.
Tuberculosis surveillance and monitoring in Europe 2017. 2017. www.ecdc.europa.eu/sites/portal/files/media/en/
publications/Publications/ecdc-tuberculosis-surveillance-monitoring-Europe-2017.pdf Date last accessed: October
25, 2019.
17 Straetemans M, Glaziou P, Bierrenbach AL, et al. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS
One 2011; 6: e20755.
18 Hauer B, Brodhun B, Altmann D, et al. Tuberculosis in the elderly in Germany. Eur Respir J 2011; 38: 467–470.
19 Blokker BM, Weustink AC, Hunink MGM, et al. Autopsy rates in the Netherlands: 35 years of decline. PLoS One
2017; 12: e0178200.
20 Rodewald AK, Bode P, Cathomas G, et al. Klinische Obduktionen in der Schweiz: Ein Statusbericht. [Clinical
autopsies in Switzerland: a status report.] Pathologe 2017; 38: 416–421.
21 Gaensbacher S, Waldhoer T, Berzlanovich A. The slow death of autopsies: a retrospective analysis of the autopsy
prevalence rate in Austria from 1990 to 2009. Eur J Epidemiol 2012; 27: 577–580.
22 Roberts IS, Benamore RE, Benbow EW, et al. Post-mortem imaging as an alternative to autopsy in the diagnosis
of adult deaths: a validation study. Lancet 2012; 379: 136–142.
https://doi.org/10.1183/23120541.00125-2019 8
TUBERCULOSIS | D. PEDRAZZOLI ET AL.
23 Tsitsikas DA, Brothwell M, Chin Aleong JA, et al. The attitudes of relatives to autopsy: a misconception. J Clin
Pathol 2011; 64: 412–414.
24 Saldana L, Abid M, McCarthy N, et al. Factors affecting delay in initiation of treatment of tuberculosis in the
Thames Valley, UK. Public Health 2013; 127: 171–177.
25 Cruz-Ferro E, Ursua-Diaz MI, Taboada-Rodriguez JA, et al. Epidemiology of tuberculosis in Galicia, Spain, 16
years after the launch of the Galician tuberculosis programme. Int J Tuberc Lung Dis 2014; 18: 134–140.
26 Nagu T, Ray R, Munseri P, et al. Tuberculosis among the elderly in Tanzania: disease presentation and initial
response to treatment. Int J Tuberc Lung Dis 2017; 21: 1251–1257.
27 Lee CT, Gollamudi SP, Myint KS, et al. Not just atypical presentation, but also atypical site: tuberculosis in elderly
adults. J Am Geriatr Soc 2016; 64: e51–e52.
28 Perez-Guzman C, Vargas MH. Mycobacterial infections in the elderly. Semin Respir Crit Care Med 2010; 31:
575–586.
29 Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment.
Int J Tuberc Lung Dis 2011; 15: 871–885.
30 Przybylski G, Dabrowska A, Pilaczynska-Cemel M, et al. Unemployment in TB patients – ten-year observation at
regional center of pulmonology in Bydgoszcz, Poland. Med Sci Monit 2014; 20: 2125–2131.
31 Kurbatova EV, Taylor A, Gammino VM, et al. Predictors of poor outcomes among patients treated for
multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis 2012; 92: 397–403.
32 Lucenko I, Riekstina V, Perevoscikovs J, et al. Treatment outcomes among drug-susceptible tuberculosis patients
in Latvia, 2006–2010. Public Health Action 2014; 4: Suppl. 2, S54–S58.
33 Mathew TA, Ovsyanikova TN, Shin SS, et al. Causes of death during tuberculosis treatment in Tomsk Oblast,
Russia. Int J Tuberc Lung Dis 2006; 10: 857–863.
34 Nagavci BL, de Gelder R, Martikainen P, et al. Inequalities in tuberculosis mortality: long-term trends in 11
European countries. Int J Tuberc Lung Dis 2016; 20: 574–581.
35 Kolappan C, Subramani R, Kumaraswami V, et al. Excess mortality and risk factors for mortality among a cohort
of TB patients from rural south India. Int J Tuberc Lung Dis 2008; 12: 81–86.
36 Borgdorff MW, Veen J, Kalisvaart NA, et al. Mortality among tuberculosis patients in The Netherlands in the
period 1993–1995. Eur Respir J 1998; 11: 816–820.
37 Chiang CY, Lee JJ, Yu MC, et al. Tuberculosis outcomes in Taipei: factors associated with treatment interruption
for 2 months and death. Int J Tuberc Lung Dis 2009; 13: 105–111.
38 GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease
Study 2015. Lancet Infect Dis 2018; 18: 261–284.
39 Public Health England. Tuberculosis in England: 2018. London, PHE, 2018.
https://doi.org/10.1183/23120541.00125-2019 9
TUBERCULOSIS | D. PEDRAZZOLI ET AL.
